Search research articles
Contact Us
Filters
Showing results (81-90 of 197) with videos related to
Page
of 20
Sort By:
SAGE Open Medicine
|
November 1, 2017
The life cycles of six multi-center adaptive clinical trials focused on neurological emergencies developed for the Advancing Regulatory Science initiative of the National Institutes of Health and US Food and Drug Administration: Case studies from the Adaptive Designs Accelerating Promising Treatments Into Trials Project
Timothy C Guetterman, Michael D Fetters, Samkeliso Mawocha, et al.
BMC Medical Ethics
|
May 3, 2015
Clinical trialist perspectives on the ethics of adaptive clinical trials: a mixed-methods analysis
Laurie J Legocki, William J Meurer, Shirley Frederiksen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 2002
Association of angiogenesis and disease outcome in node-positive breast cancer patients treated with adjuvant cyclophosphamide, doxorubicin, and fluorouracil: a Cancer and Leukemia Group B correlative science study from protocols 8541/8869
Anthony J Guidi, Donald A Berry, Gloria Broadwater, et al.
Annals of Surgery
|
July 30, 2015
Impact of neoadjuvant chemotherapy in stage II-III triple negative breast cancer on eligibility for breast-conserving surgery and breast conservation rates: surgical results from CALGB 40603 (Alliance)
Mehra Golshan, Constance T Cirrincione, William M Sikov, et al.
Cancer
|
December 27, 2017
Distinguishing between CISNET model results versus CISNET models
Donald A Berry, Harry J de Koning, Sandra J Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 21, 2007
Toxicity of older and younger patients treated with adjuvant chemotherapy for node-positive breast cancer: the Cancer and Leukemia Group B Experience
Hyman B Muss, Donald A Berry, Constance Cirrincione, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
August 2, 2005
Primary hyperparathyroidism and osteosarcoma: examination of a large cohort identifies three cases of fibroblastic osteosarcoma
Camilo Jimenez, Ying Yang, Hyung-Woo Kim, et al.
JAMA Oncology
|
May 12, 2017
Association of Minimal Residual Disease With Clinical Outcome in Pediatric and Adult Acute Lymphoblastic Leukemia: A Meta-analysis
Donald A Berry, Shouhao Zhou, Howard Higley, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 6, 2007
Recommended changes to oncology clinical trial design: revolution or evolution?
Mark J Ratain, Rachel W Humphrey, Gary B Gordon, et al.
Clinical Trials (London, England)
|
February 1, 2017
A conceptual model for the development process of confirmatory adaptive clinical trials within an emergency research network
Samkeliso C Mawocha, Michael D Fetters, Laurie J Legocki, et al.
Page
of 20
Search research articles
Search
Showing results (81-90 of 197) with videos related to
Sort By:
Page
of 20
SAGE Open Medicine
|
November 1, 2017
The life cycles of six multi-center adaptive clinical trials focused on neurological emergencies developed for the Advancing Regulatory Science initiative of the National Institutes of Health and US Food and Drug Administration: Case studies from the Adaptive Designs Accelerating Promising Treatments Into Trials Project
Timothy C Guetterman, Michael D Fetters, Samkeliso Mawocha, et al.
BMC Medical Ethics
|
May 3, 2015
Clinical trialist perspectives on the ethics of adaptive clinical trials: a mixed-methods analysis
Laurie J Legocki, William J Meurer, Shirley Frederiksen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 2002
Association of angiogenesis and disease outcome in node-positive breast cancer patients treated with adjuvant cyclophosphamide, doxorubicin, and fluorouracil: a Cancer and Leukemia Group B correlative science study from protocols 8541/8869
Anthony J Guidi, Donald A Berry, Gloria Broadwater, et al.
Annals of Surgery
|
July 30, 2015
Impact of neoadjuvant chemotherapy in stage II-III triple negative breast cancer on eligibility for breast-conserving surgery and breast conservation rates: surgical results from CALGB 40603 (Alliance)
Mehra Golshan, Constance T Cirrincione, William M Sikov, et al.
Cancer
|
December 27, 2017
Distinguishing between CISNET model results versus CISNET models
Donald A Berry, Harry J de Koning, Sandra J Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 21, 2007
Toxicity of older and younger patients treated with adjuvant chemotherapy for node-positive breast cancer: the Cancer and Leukemia Group B Experience
Hyman B Muss, Donald A Berry, Constance Cirrincione, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
August 2, 2005
Primary hyperparathyroidism and osteosarcoma: examination of a large cohort identifies three cases of fibroblastic osteosarcoma
Camilo Jimenez, Ying Yang, Hyung-Woo Kim, et al.
JAMA Oncology
|
May 12, 2017
Association of Minimal Residual Disease With Clinical Outcome in Pediatric and Adult Acute Lymphoblastic Leukemia: A Meta-analysis
Donald A Berry, Shouhao Zhou, Howard Higley, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 6, 2007
Recommended changes to oncology clinical trial design: revolution or evolution?
Mark J Ratain, Rachel W Humphrey, Gary B Gordon, et al.
Clinical Trials (London, England)
|
February 1, 2017
A conceptual model for the development process of confirmatory adaptive clinical trials within an emergency research network
Samkeliso C Mawocha, Michael D Fetters, Laurie J Legocki, et al.
Page
of 20